News
INGN
5.75
+2.86%
0.16
Weekly Report: what happened at INGN last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at INGN last week (0126-0130)?
Weekly Report · 02/02 09:15
Weekly Report: what happened at INGN last week (0119-0123)?
Weekly Report · 01/26 09:15
B. Riley Securities Reaffirms Their Buy Rating on Inogen (INGN)
TipRanks · 01/22 10:06
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Inogen (INGN)
TipRanks · 01/22 10:01
Weekly Report: what happened at INGN last week (0112-0116)?
Weekly Report · 01/19 09:16
Inogen (NASDAQ:INGN shareholders incur further losses as stock declines 11% this week, taking five-year losses to 86%
Simply Wall St · 01/15 10:32
Analysts Offer Insights on Healthcare Companies: Inogen (INGN), Exelixis (EXEL) and Ultragenyx Pharmaceutical (RARE)
TipRanks · 01/13 04:10
Inogen reports preliminary Q4 revenue $82M, consensus $88.6M
TipRanks · 01/12 14:20
Inogen sees Q4 net sales of $82M and $349M for the full-year 2025
Seeking Alpha · 01/12 14:16
Oxygen concentrator maker Inogen's prelim Q4 revenue grows 2% on strong B2B performance
Reuters · 01/12 13:41
Inogen Estimates Preliminary Total Revenue In Q4 To Be ~$82M, Up ~2% YoY; Expects FY25 Preliminary Revenue To Be ~$349M, Up ~4% YoY
Benzinga · 01/12 13:38
Inogen Lowers FY2025 Sales Guidance from $354.000M-$357.000M to $349.000M vs $355.600M Est
Benzinga · 01/12 13:34
*Inogen: Saw Shift in Timing of Some Large Customer Orders Into 1st Half of 2026 >INGN
Dow Jones · 01/12 13:34
*Inogen Sees 2025 Rev About $349M >INGN
Dow Jones · 01/12 13:33
*Inogen Sees 4Q Rev About $82M >INGN
Dow Jones · 01/12 13:33
*Inogen Expects to Achieve Positive Adjusted Ebitda For Full-Year 2025 >INGN
Dow Jones · 01/12 13:33
INOGEN INC - ESTIMATES Q4 2025 REVENUE AT $82 MLN, 2% GROWTH YOY
Reuters · 01/12 13:30
Press Release: Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025
Dow Jones · 01/12 13:30
Weekly Report: what happened at INGN last week (0105-0109)?
Weekly Report · 01/12 09:16
More
Webull provides a variety of real-time INGN stock news. You can receive the latest news about Inogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About INGN
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.